Moolec Science (MLECW) Short-term Investments (2022 - 2025)
Moolec Science (MLECW) posted Short-term Investments of $8.3 million for Q2 2025, up 179.32% sequentially from -$10.4 million in Q4 2024, and down 43.72% YoY from $14.7 million in Q2 2024.
Moolec Science (MLECW) Short-term Investments (2022 - 2025) Analysis & Trends
Moolec Science has reported Short-term Investments for 4 years, with the latest figure at $8.3 million in Q2 2025.
- Quarterly Short-term Investments fell 43.72% year-over-year to $8.3 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $8.3 million (down 43.72% YoY) and the FY2025 annual result came in at $8.3 million, down 43.72% from the prior year.
- Short-term Investments improved to $8.3 million in Q2 2025 per MLECW's latest filing, from -$10.4 million in the prior quarter.
- Over five years, Short-term Investments peaked at $14.7 million in Q2 2024 and troughed at -$10.4 million in Q4 2024.
- A 4-year average of $771323.4 and a median of $263.0 in 2023 frame the typical range for Short-term Investments.
- The widest YoY moves for Short-term Investments: up 4692.8% in 2024, down 93.89% in 2024.
- Over 4 years, Short-term Investments stood at -$2.1 million in 2022, then tumbled by 161.06% to -$5.4 million in 2023, then tumbled by 93.89% to -$10.4 million in 2024, then soared by 179.32% to $8.3 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $8.3 million, -$10.4 million, and $14.7 million for Q2 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8.25 Mn |
| Dec 31, 2024 | -10.41 Mn |
| Jun 30, 2024 | 14.67 Mn |
| Dec 31, 2023 | -5.37 Mn |
| Sep 30, 2023 | 263.00 |
| Jun 30, 2023 | 306,034.00 |
| Jun 30, 2022 | -2.06 Mn |